Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular...

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Etk (Erythroid-associated tyrosine kinase) is a Tec family kinase involved in cell proliferation, differentiation, and motility.
• Etk is expressed in hematopoietic, epithelial, and endothelial cells.
• Etk's role in cellular transformation and cancer warrants further investigation.

Purpose of the Study:

• To generate intrabodies targeting Etk using a single-domain antibody phage display library.
• To evaluate the efficacy of these intrabodies in blocking Etk kinase activity and inhibiting cancer cell growth.

Main Methods:

• Utilized a human single-domain antibody phage display library to isolate Etk-specific antibodies.
• Expressed these single-domain antibodies as intrabodies within transformed cells.
• Assessed Etk binding, kinase activity blockade, and inhibition of clonogenic cell growth in soft agar.

Main Results:

• Generated single-domain antibodies that specifically bind to recombinant Etk.
• Demonstrated efficient blockade of Etk kinase activity by these antibodies.
• Showed that intrabody expression in transformed cells led to significant Etk inhibition and reduced clonogenic growth.

Conclusions:

• Etk plays a role in Src-induced cellular transformation and is a potential target for cancer therapy.
• The single-domain antibody-based intrabody system is effective for intracellular targeting of signaling molecules like Etk.
• This approach offers a promising strategy for developing novel cancer interventions.